Repligen Corporation provided earnings guidance for the fiscal year 2021. For the period, the company's total revenue is expected to be in the range of $655-$665 million, an increase from previous guidance of $625-$645 million. The company expected overall revenue growth of 79%-82% and 77%-80% at constant currency. Organic growth is expected to be in the range of 65%-68%, an increase from previous guidance of 57%-62%. Revenue from COVID-related programs is expected to be in the range of $175-$180 million, an update to previous guidance of $170-$180 million. Income from operations is expected to be in the range of $165-$169 million on a GAAP basis, an increase from previous guidance of $156-$161 million. Net income is expected to be in the range of $125-$128 million on a GAAP basis, an increase from previous guidance of $118-$122 million. Fully diluted GAAP EPS is expected to be in the range of $2.19-$2.24, an increase from previous guidance of $2.08-$2.15.